Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Panguian trial of ultrasound-guided intra-articular versus intramuscular betamethasone for rheumatoid arthritis synovitis
2017-003425-15Phase 4Active
- Sponsor
- Knowledge Centre for Rheumatology and Back Diseases
- Start
- Sep 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of betamethasone in synovitis and rheumatoid arthritis (RA) (2 arms), sponsored by Knowledge Centre for Rheumatology and Back Diseases. Primary endpoint: Ultrasound synovitis remission at week 4. Started Sep 2017; status: active.
02
Drugs
betamethasone
03
Conditions
synovitisrheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2017-003425-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-003425-15.